University of Maryland School of Medicine Dean Mark T. Gladwin Leads International Randomized Clinical Trials for Novel Sickle Cell Treatment
November 30, 2023
November 30, 2023
BALTIMORE, Maryland, Nov. 30 (TNSres) -- The University of Maryland School of Medicine issued the following news:
University of Maryland School of Medicine Dean Mark T. Gladwin, MD will join prominent scientists and government health officials this week at a Symposium in Rio De Janeiro, Brazil, to discuss new treatments for sickle cell disease (SCD). The disease, which afflicts 20 million people around the world, notably affects the Black community, reducing their average lifespan b . . .
University of Maryland School of Medicine Dean Mark T. Gladwin, MD will join prominent scientists and government health officials this week at a Symposium in Rio De Janeiro, Brazil, to discuss new treatments for sickle cell disease (SCD). The disease, which afflicts 20 million people around the world, notably affects the Black community, reducing their average lifespan b . . .